Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
Submitted by
admin
on June 19, 2009 - 9:01am
Source:
Seeking Alpha
News Tags:
Spectrum Pharmaceuticals
pipelines
Fusilev
Eoquin
Headline:
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
Do Not Allow Advertisers to Use My Personal information
